BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7264507)

  • 1. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW; Waxman MB; Colman JM
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disopyramide-induced Torsade de Pointes.
    Tzivoni D; Keren A; Stern S; Gottlieb S
    Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    Croft CH; Kennelly BM
    S Afr Med J; 1981 Jun; 59(24):871-3. PubMed ID: 7233313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular pacing in atypical ventricular tachycardia.
    Keren A; Tzivoni D; Golhman JM; Corcos P; Benhorin J; Stern S
    J Electrocardiol; 1981; 14(2):201-5. PubMed ID: 7276791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical ventricular tachycardia due to disopyramide].
    Feigl D; Ashkenazi J; Schwarzmann H
    Harefuah; 1982 Mar; 102(6):246-7. PubMed ID: 7160719
    [No Abstract]   [Full Text] [Related]  

  • 13. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three cases of torsades de pointes due to anti-arrhythmic agents].
    Yasuda M; Toda I; Akioka K; Teragaki M; Oku H; Takeuchi K; Takeda T; Inoue E; Ikuno Y; Horiguchi T
    Nihon Naika Gakkai Zasshi; 1986 Sep; 75(9):1262-6. PubMed ID: 3794468
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
    Roden DM; Woosley RL; Primm RK
    Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial activation patterns of torsade de pointes in canine hearts with quinidine-induced long QT interval but without myocardial infarction.
    Inoue H; Murakawa Y; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
    Am Heart J; 1986 Jun; 111(6):1080-7. PubMed ID: 3716981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    Riccioni N; Castiglioni M; Bartolomei C
    Am Heart J; 1983 May; 105(5):870-1. PubMed ID: 6846134
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paradoxic response to disopyramide and quinidine (author's transl)].
    Breithardt G; Seipel L; Haerten K
    Z Kardiol; 1980 Aug; 69(8):556-61. PubMed ID: 7445656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.